Founder & Chief Executive Officer
Dr. Steen co-founded Lygos to create sustainable ingredients that solve environmental challenges.
Chief Financial Officer
Mr. Dille brings nearly 20 years of corporate finance and investment banking experience.
Chief Executive Officer Librede
Dr. Poulos is co-founder of Librede, a wholly owned cannabinoid production subsidiary of Lygos.
Chief Technology Officer
Dr. Ohler leads the development and scale-up of Lygos’ fermentation-enabled production process.
Vice President of Biology R&D
Dr. Conley oversees Lygos’ proprietary protein, metabolic and strain bioengineering activities.
Chief Patent Counsel
Dr. Rao brings a wealth of experience focused on IP strategy, procurement and protection.
Jay D. Keasling
Professor of Chemical Engineering and Bioengineering at the University of California-Berkeley
President of the Society for Industrial Microbiology and Biotechnology
Industrial Biotechnology Consultant; Former CEO of Microbia, Inc.
President of KiwiChem International, Inc.
Professor of Chemical & Biochemical Engineering; Technological Innovation Faculty Director at MIT
Chief Technology Officer of Nature's Fynd; Former Chief Technology Officer at BioAmber, Inc.
Stephen del Cardayre
Vice President of Life Science Research & Development of Renewable Energy Group & LS9, Inc.